Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation.

Peng-Xiang WangYang XuYun-Fan SunJian-Wen ChengKai-Qian ZhouSui-Yi WuBo HuZe-Fan ZhangWei GuoYa CaoXiao-Wu HuangJian ZhouJia FanXin-Rong Yang

Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)

CTCs may be a useful biomarker to evaluate recurrence risk following LTx in patients with HCC. Evaluation based on CTC detection may enhance the post-transplant management of HCC, and improve the therapeutic efficacy of LTx.

Keyphrases

patients undergoing
circulating tumor cells
loop mediated isothermal amplification
induced apoptosis
real time pcr
label free
free survival
cell cycle arrest
signaling pathway
oxidative stress
circulating tumor
sensitive detection
breast cancer risk